Session Details
[AL22]SHIONOGI & CO., LTD.
Thu. Mar 27, 2025 10:15 AM - 10:55 AM JST
Thu. Mar 27, 2025 1:15 AM - 1:55 AM UTC
Thu. Mar 27, 2025 1:15 AM - 1:55 AM UTC
Room 2 (Fukuoka International Congress Center: 501 [5F])
Chair: Kenji Yamawaki (SHIONOGI & CO., LTD.)
[App translation available]
[AL22]Discovery of ensitrelvir, a COVID-19 treatment targeting 3CL protease
○Yuki Tachibana1, Yuto Unoh1, Shota Uehara1, Haruaki Nobori1, Teruhisa Kato1 (1. SHIONOGI & CO., LTD.)